Management of Single Positive Blood Culture for Staph Epidermidis in a Clinically Stable Patient
In a clinically stable, non-septic patient with only one bottle growing Staph epidermidis and the other bottle sterile at 72 hours, you should stop antibiotics and obtain repeat blood cultures off antibiotics to confirm clearance. This single positive bottle most likely represents contamination rather than true bacteremia.
Key Diagnostic Considerations
The growth pattern strongly suggests contamination rather than true infection. When coagulase-negative staphylococci grow in only one bottle of a blood culture set (discordant growth), contamination is present in 98% of cases 1. This finding is remarkably consistent—in a large two-period study of 858 first CoNS-positive cultures per patient, 624/636 (98.1%) of discordant sets were contaminants, with only 1.9% representing true bacteremia 1.
Why This Matters Clinically
Multiple lines of evidence support this interpretation:
Growth pattern analysis: True coagulase-negative staphylococcal bacteremia typically produces positive results in both aerobic and anaerobic bottles in 85% of cases, whereas contamination shows growth in both bottles only 30% of the time 2
Multiple positive cultures: A high proportion of positive blood cultures from multiple sites remains the best indication for true catheter-related bloodstream infection (CRBSI) due to coagulase-negative staphylococci 3
Clinical context: Your patient is not septic and clinically stable, which further supports contamination over true infection
Recommended Management Algorithm
Step 1: Discontinue Antibiotics
Stop antibiotics immediately in this clinically stable patient without intravascular or orthopedic hardware. The IDSA guidelines explicitly state that patients with uncomplicated coagulase-negative staphylococcal CRBSI can be observed without antibiotics if they have no intravascular or orthopedic hardware, the catheter is removed (if present), and the patient is clinically stable 3.
Step 2: Obtain Repeat Blood Cultures
Yes, obtain repeat blood cultures off antibiotics to confirm absence of bacteremia. This is specifically recommended by IDSA guidelines: "additional blood cultures (performed on samples collected when the patient is not receiving antibiotics) are obtained after catheter withdrawal to confirm the absence of bacteremia" 3.
Step 3: Clinical Monitoring
Monitor for:
- Fever or hypothermia
- Tachycardia
- Signs of systemic inflammatory response
- Any clinical deterioration
If the patient develops ≥3 SIRS criteria or 2 SIRS criteria with a central venous catheter, the probability of true bacteremia increases significantly (72.3% and 56.7% respectively) 4, warranting reconsideration of treatment.
Important Caveats and Pitfalls
When to Reconsider This Approach
You should NOT stop antibiotics if:
- The patient has intravascular hardware (prosthetic valves, pacemakers, vascular grafts)
- The patient has orthopedic hardware
- A central venous catheter remains in place and cannot be removed
- The patient develops clinical instability or signs of infection
- This is Staphylococcus lugdunensis (treat like S. aureus with 4-6 weeks of therapy) 3
If a Catheter is Present
If there is a central venous catheter:
- Remove the catheter if possible for any suspected CRBSI
- If the catheter is removed and the patient has no hardware, observation without antibiotics is acceptable with repeat cultures 3
- If the catheter must be retained, treat with 10-14 days of systemic antibiotics plus antibiotic lock therapy 3
- If the catheter is removed, treat for only 5-7 days 5
Additional Diagnostic Clues
Time to positivity can provide additional information, though you already have your answer at 72 hours:
- Contamination typically shows time to positivity >20 hours 6
- True bacteremia usually shows positivity <48 hours, often <24 hours for catheter-related infections 7, 2
- High-grade bacteremia (>100 CFU/ml) typically shows positivity ≤16 hours 6
The Bottom Line
Your patient's single positive bottle at 72 hours with clinical stability represents contamination in 98% of cases. Stop antibiotics, obtain repeat blood cultures off antibiotics to document clearance, and monitor clinically. This approach avoids unnecessary antibiotic exposure while maintaining patient safety through appropriate follow-up cultures and clinical surveillance 3, 1.